Covid-19: New data on Oxford AstraZeneca vaccine backs 12 week dosing interval
Jacqui Wise
Abstract
Thank you for your interest in spreading the word about The BMJ.NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address. Username * Your Email * Send To * You are going to email the following Covid-19: New data on Oxford AstraZeneca vaccine backs 12 week dosing interval Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)MedicineDosingWorld Wide WebSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakInternet privacyComputer scienceVirologyPharmacologyInternal medicineInfectious disease (medical specialty)OutbreakDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesVaccine Coverage and Hesitancy